Evaluation and management of abdominal compartment syndrome in the Emergency Department
Executive Summary
Abdominal Compartment Syndrome (ACS) is a critical, potentially lethal condition characterized by a sustained increase in intra-abdominal pressure (IAP) exceeding 20 mmHg, accompanied by new-onset organ dysfunction. While intra-abdominal hypertension (IAH) is present in up to one-third of intensive care admissions, ACS represents a severe progression with significantly higher mortality rates. Because history and physical examinations are notoriously unreliable—failing to identify the condition in 40% to 60% of cases—the gold standard for diagnosis is the objective measurement of IAP, typically performed via a transvesical (bladder) catheter.
Management requires a multi-pronged approach: improving abdominal wall compliance, evacuating intraluminal and extraluminal contents, optimizing fluid resuscitation to avoid hypervolemia, and, in refractory cases, performing a surgical decompressive laparotomy. Early recognition in the emergency department (ED) is vital, especially for patients undergoing "boarding" or receiving massive fluid resuscitation.
Foundational Concepts and Definitions
The intra-abdominal compartment is a closed space bounded by the diaphragm, pelvic floor, and abdominal walls. Normal IAP ranges from 2–5 mmHg, though this baseline is higher in critically ill patients (5–7 mmHg), morbidly obese individuals (9–16 mmHg), and pregnant women (approximately 14 mmHg).
Classification of ACS
Primary: Results from intrinsic abdominal injury or disease (e.g., abdominal surgery, trauma).
Secondary: Results from extrinsic etiologies not originating in the abdominopelvic region (e.g., sepsis, major burns, massive fluid resuscitation).
Recurrent: Redevelopment of ACS following the resolution of a previous episode.
Pathophysiology and Organ Dysfunction
ACS functions similarly to other compartment syndromes, where increased pressure deranges tissue perfusion. This leads to a cascade of multisystem failures:
Renal: The kidneys are extremely sensitive to IAP; elevated pressure reduces renal perfusion, leading to oliguria, anuria, and activation of the renin–angiotensin–aldosterone system.
Gastrointestinal: Bowel edema and ischemia can cause mucosal barrier failure, leading to the translocation of bacteria and cytotoxins.
Neurological: Increased IAP can elevate intracranial pressure by obstructing venous outflow or disrupting the blood-brain barrier via inflammatory markers like interleukin-6.
Cardiovascular: Pressure decreases venous return and reduces cardiac output, further exacerbating renal and splanchnic hypoperfusion.
Respiratory: Reduced diaphragmatic mobility decreases ventilatory capacity, causing respiratory acidosis and hypoxia.
Risk Factors and Clinical Presentation
Clinicians must maintain a high index of suspicion for patients with the following major risk factors:
Diminished Abdominal Compliance: Recent surgery, obesity, or major burns.
Increased Intraluminal Contents: Gastroparesis, ileus, or colonic pseudo-obstruction.
Increased Abdominal Contents: Ascites, hemoperitoneum, pancreatitis, or large tumors.
Capillary Leak/Fluid Resuscitation: Sepsis, acidemia, and massive fluid resuscitation (>3–5 L in 24 hours).
Clinical Limitations
Physical findings such as abdominal distension and absent bowel sounds increase the suspicion of ACS but are not sensitive enough to exclude the diagnosis. Symptoms in conscious patients may include worsening pain, abdominal distension, difficulty breathing, and orthopnea.
Diagnostic Evaluation
Intra-Abdominal Pressure (IAP) Measurement
IAP measurement is mandatory for any critically ill patient with risk factors and new organ failure. The transvesical (bladder) technique is the standard ED method.
Standard Measurement Protocol:
Preparation: Place the patient supine and provide analgesia.
Transducer Setup: Zero the pressure transducer at the mid-axillary line at the level of the iliac crest (bladder level).
Instillation: Instill a maximum of 25 mL of warm sterile saline into the bladder. (Volumes >25 mL or cold fluids can cause false elevations due to detrusor muscle contraction).
Stabilization: Wait at least 30 seconds for the detrusor muscle to relax.
Reading: Obtain the pressure reading at end-expiration.
Imaging and Laboratory Markers
Computed Tomography (CT): May show the "round belly sign" (AP-to-transverse diameter ratio > 0.80), inferior vena cava collapse, thickened bowel walls, or a Peritoneal-to-Abdominal Height Ratio (PAR) ≥ 0.52.
Lactate: While L-lactate is a nonspecific marker of ischemia, D-lactate (a product of intestinal bacterial metabolism) shows promise in specifically detecting intestinal ischemia in ACS.
Iyer Decision Tool: Identification of IAH may be assisted by assessing six factors: abdominal distension, hemoperitoneum/pneumoperitoneum, obesity, fluid resuscitation >2.3 L, SOFA score >4, and lactate >1.4 mmol/L.
Management Strategies
Management focuses on the dual goals of reducing IAP and optimizing end-organ perfusion (APP > 60 mmHg).
Medical and Nonsurgical Interventions
Surgical Intervention
Surgical decompression via laparotomy with fascial release is the definitive treatment for ACS when medical management fails. This intervention is associated with immediate improvements in hemodynamics, renal function, and respiratory physiology. Delaying decompression beyond four days (specifically in pancreatitis-related ACS) is associated with worse outcomes. After surgery, temporary abdominal closure techniques are used to manage the "open abdomen" until closure is possible, typically 5–7 days later.
Conclusion and Disposition
ACS is a time-sensitive emergency. Most patients require admission to a critical care unit for frequent IAP monitoring (every 4–6 hours) and intensive organ support. Prognosis is heavily dependent on rapid diagnosis and the mitigation of risk factors like excessive fluid resuscitation. For emergency clinicians, the "clinical bottom line" is clear: in any critically ill patient with worsening organ function (especially renal), IAP must be measured to rule out this potentially fatal syndrome.
